Supporting vaccine research and development: Launching the EPI knowledge hub
Innovations such as vaccines are needed to enable global preparedness for newly emerging and re-emerging infectious diseases. Access to life-saving interventions including vaccines is essential for preparing and responding to epidemics, including COVID-19. Meeting this need will requires accessible information and resources that can be readily shared openly to enable knowledge sharing and networking communication between stakeholders in vaccine development.
With the launch of the Epidemic Preparedness Innovations (EPI) knowledge hub, the Coalition for Epidemic Preparedness and Innovations (CEPI) aims to bring together knowledge, tools and methods to support vaccine researchers, developers, funders and anybody working on or interested in the field of epidemic preparedness innovations.
In line with CEPI’s objectives this hub, embedded within The Global Health Network aims to:
- Provide expert assistance to developers and investigators to enhance vaccine development efforts.
- Engage stakeholders
- Drive efficiencies in vaccine development to reduce costs, provide access to CEPI products, and develop partnerships
- Ensure open access to data, results and publications arising from CEPI’s funding and facilitate access to materials to accelerate vaccine development
- Develop partnerships for knowledge sharing and quality relations between partners in vaccine development in alignment with CEPI objectives
- Provide capacity development in affected countries through clinical trial tools, training, workshops, and web-learning courses
- Facilitate professional development and knowledge exchange between vaccine developers, investigational sites and funding agencies
We look forward to you joining, contributing and using the EPI knowledge hub as a reliable and up-to-date source of information and a platform to exchange knowledge on epidemic preparedness innovation. We welcome your feedback on how you would like to see the EPI knowledge hub evolve, so please do comment below.
CEPI is an innovative global partnership between public, private, philanthropic, and civil society organizations working to accelerate the development of vaccines against emerging infectious diseases and to enable equitable access to these vaccines for affected populations during outbreaks.
CEPI was launched at the World Economic Forum in Davos in 2017 as the result of a consensus that a coordinated, international, and intergovernmental plan was needed to develop and deploy new vaccines to prevent future epidemics.
CEPI and its partners work on the following priority diseases: MERS-CoV, Lassa fever, Nipah, Rift Valley Fever, Chikungunya, Marburg virus and COVID-19. CEPI has moved with great urgency and in coordination with WHO in response to the emergence of COVID-19. CEPI has initiated 9 partnerships to develop vaccines against the novel coronavirus. The programmes will leverage rapid response platforms already supported by CEPI as well as new partnerships. The aim is to advance COVID-19 vaccine candidates into clinical testing as quickly as possible.
Follow our news page for the latest updates.
About The Global Health Network
Faster and better research is critical to solving the world’s biggest health challenges. The Global Health Network enables researchers and institutions to share best practice and know-how with each other to drive progress, while empowering local health professionals undertaking research in the world’s most vulnerable settings. The Global Health Network facilitates sustainable health improvements through sharing of research methods, knowledge and experience through an open-access online platform and face-to-face within varied healthcare settings. It delivers training, skills and career development to frontline health workers, no matter where they are or how resource-constrained their environment may be. The result is easier, faster, better research to help address the world's biggest health challenges.